• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Identifying and Treating Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病的识别与治疗
Fed Pract. 2019 Jan;36(1):20-29.
2
Similarities and differences between pediatric and adult nonalcoholic fatty liver disease.儿童与成人非酒精性脂肪性肝病之间的异同
Metabolism. 2016 Aug;65(8):1161-71. doi: 10.1016/j.metabol.2016.01.008. Epub 2016 Jan 20.
3
Low and High Birth Weights Are Risk Factors for Nonalcoholic Fatty Liver Disease in Children.低出生体重和高出生体重是儿童非酒精性脂肪性肝病的危险因素。
J Pediatr. 2017 Aug;187:141-146.e1. doi: 10.1016/j.jpeds.2017.03.007. Epub 2017 Mar 30.
4
Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.黄连素改善非酒精性脂肪性肝病中的糖异生和脂质代谢。
BMC Endocr Disord. 2017 Feb 28;17(1):13. doi: 10.1186/s12902-017-0165-7.
5
Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.在退伍军人健康管理局中识别非酒精性脂肪性肝病的肝纤维化程度。
Dig Dis Sci. 2018 Sep;63(9):2259-2266. doi: 10.1007/s10620-018-5123-3. Epub 2018 May 19.
6
[Nonalcoholic Fatty Liver Disease and Weight Loss].[非酒精性脂肪性肝病与体重减轻]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2018 Oct 30;40(5):597-602. doi: 10.3881/j.issn.1000-503X.10524.
7
Diets and nonalcoholic fatty liver disease: the good and the bad.饮食与非酒精性脂肪性肝病：利弊分析
Clin Nutr. 2014 Apr;33(2):186-90. doi: 10.1016/j.clnu.2013.11.003. Epub 2013 Nov 8.
8
Nonalcoholic Fatty Liver Disease (NAFLD)-A New Cardiovascular Risk Factor in Peritoneal Dialysis Patients.非酒精性脂肪性肝病（NAFLD）——腹膜透析患者的一种新的心血管危险因素。
Perit Dial Int. 2016 Jul-Aug;36(4):427-32. doi: 10.3747/pdi.2014.00223. Epub 2015 Oct 16.
9
Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.与健康正常体重个体相比，不同程度非酒精性脂肪性肝病患者的肝转录组特征。
Am J Physiol Gastrointest Liver Physiol. 2019 Apr 1;316(4):G462-G472. doi: 10.1152/ajpgi.00358.2018. Epub 2019 Jan 17.
10
[Overview of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Management].[非酒精性脂肪性肝病/非酒精性脂肪性肝炎管理概述]
Yakugaku Zasshi. 2019;139(9):1147-1153. doi: 10.1248/yakushi.19-00011-1.

引用本文的文献

1
Predictive Algorithm for Hepatic Steatosis Detection Using Elastography Data in the Veterans Affairs Electronic Health Records.利用退伍军人事务部电子健康记录中的弹性成像数据检测肝脂肪变性的预测算法。
Dig Dis Sci. 2023 Dec;68(12):4474-4484. doi: 10.1007/s10620-023-08043-8. Epub 2023 Oct 21.
2
The effects of seaweed supplementation consumption for improvement of liver injury in patients with non-alcoholic fatty liver disease: a systematic review.补充食用海藻对改善非酒精性脂肪性肝病患者肝损伤的影响：一项系统评价
Clin Exp Hepatol. 2022 Sep;8(3):171-177. doi: 10.5114/ceh.2022.118275. Epub 2022 Aug 4.
3
Population Management of Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病的人群管理
Fed Pract. 2019 Feb;36(2):72-82.

本文引用的文献

1
Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.在退伍军人健康管理局中识别非酒精性脂肪性肝病的肝纤维化程度。
Dig Dis Sci. 2018 Sep;63(9):2259-2266. doi: 10.1007/s10620-018-5123-3. Epub 2018 May 19.
2
Natural history of nonalcoholic fatty liver disease: A prospective follow-up study with serial biopsies.非酒精性脂肪性肝病的自然史：一项采用系列活检的前瞻性随访研究。
Hepatol Commun. 2017 Dec 27;2(2):199-210. doi: 10.1002/hep4.1134. eCollection 2018 Feb.
3
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis.非酒精性脂肪性肝炎的病因、发病机制及治疗
N Engl J Med. 2017 Nov 23;377(21):2063-2072. doi: 10.1056/NEJMra1503519.
4
Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration.退伍军人事务部经活检证实的非酒精性脂肪性肝病进展的危险因素。
Aliment Pharmacol Ther. 2018 Jan;47(2):268-278. doi: 10.1111/apt.14411. Epub 2017 Nov 8.
5
Long-term Sustainability of Diabetes Prevention Approaches: A Systematic Review and Meta-analysis of Randomized Clinical Trials.长期可持续性的糖尿病预防方法：随机临床试验的系统评价和荟萃分析。
JAMA Intern Med. 2017 Dec 1;177(12):1808-1817. doi: 10.1001/jamainternmed.2017.6040.
6
Weight and Metabolic Outcomes 12 Years after Gastric Bypass.胃旁路术后12年的体重及代谢结果
N Engl J Med. 2017 Sep 21;377(12):1143-1155. doi: 10.1056/NEJMoa1700459.
7
Use of Liver Imaging and Biopsy in Clinical Practice.肝脏成像与活检在临床实践中的应用。
N Engl J Med. 2017 Aug 24;377(8):756-768. doi: 10.1056/NEJMra1610570.
8
Efficacy of dietary and physical activity intervention in non-alcoholic fatty liver disease: a systematic review.饮食和体育活动干预对非酒精性脂肪性肝病的疗效：一项系统评价
BMJ Open Gastroenterol. 2017 Jun 1;4(1):e000139. doi: 10.1136/bmjgast-2017-000139. eCollection 2017.
9
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.非酒精性脂肪性肝病的诊断与管理：美国肝病研究协会的实践指南
Hepatology. 2018 Jan;67(1):328-357. doi: 10.1002/hep.29367. Epub 2017 Sep 29.
10
The Obesity Epidemic in the Veterans Health Administration: Prevalence Among Key Populations of Women and Men Veterans.退伍军人健康管理局中的肥胖流行情况：退伍军人女性和男性关键人群中的患病率
J Gen Intern Med. 2017 Apr;32(Suppl 1):11-17. doi: 10.1007/s11606-016-3962-1.

非酒精性脂肪性肝病的识别与治疗

Identifying and Treating Nonalcoholic Fatty Liver Disease.

作者信息

Hunt Christine M, Turner Marsha J, Gifford Elizabeth J, Britt Rachel B, Su Grace L

机构信息

is a Physician Affiliate, is a Research Health Science Specialist at the Cooperative Studies Program Epidemiology Center, and is a Hepatology Clinical Pharmacy Specialist, all at Durham Veterans Affairs Health Care System in North Carolina. is an Assistant Research Professor at the Sanford School of Public Policy at Duke University in Durham. is a Professor of Medicine at the VA Ann Arbor Healthcare Systems in Michigan and at the University of Michigan in Ann Arbor. Christine Hunt also is an Adjunct Associate Professor of Medicine at Duke University Medical Center in Durham, North Carolina.

出版信息

Fed Pract. 2019 Jan;36(1):20-29.

PMID:30766414
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6366580/
Abstract

NAFLD improves with 7% or greater weight loss.

摘要

非酒精性脂肪性肝病（NAFLD）在体重减轻7%或更多时会有所改善。